Biotech Values

[exwannabe]

Why would such a technical matter as the accounting treatment of an asset sale have to delay a quarterly CC?

Would not entire financial presentation have to be deleted? You can't use safe harbor clauses to cover material information already known to be wrong.

I do agree that it would make sense to go with that segment nixed. But it would seam odd to discuss the Q numbers and not discuss the numbers